Objectives: Bishphenol A (BPA) is a representative endocrine disruptor and is also known as a xenoestrogen. The objective of the present study is to investigate how many patients are exposed to BPA and to analyze the relationships between serum BPA concentration, bone mineral density (BMD) and biochemical bone markers in postmenopausal women with osteoporosis. Methods: Total 51 patients were enrolled for measuring BPA and clinical variables including BMD and bone markers. The relationship between BPA and clinical variables were analyzed by the Pearson's correlation test and the Kruskal-Wallis test. Serum BPA concentration was measured by enzyme linked immunosorbent assay (ELISA). Results: BPA was detected in all samples. The mean BPA concentration was 1.44 ± 0.52 ng/mL. There was no statistically significant correlation between BPA and clinical variables. Conclusion: There was no statistical significance between serum BPA concentration and clinical variables related to bone metabolism. To clarify the effect of BPA on bone metabolism, further large scaled and high risk group investigation may be needed.
INTRODUCTION
produced annually all around the world and widely applied in the manufacture of an epoxy resin, mainly used to produce a container or a package for foods and beverages, or a polycarbonate plastic. [2] BPA is widely and continuously exposed to human through a diet and is also exposed by the other paths such as through skin and dust etc. In fact, according to a research performed in the US, measureable BPA was found in approximately 93-95% of the subjects through urine. [3, 4] The mechanism that BPA shows inappropriate effect in the body is known as estrogen like mechanism; [5] besides, a decrease of the function in a pancreatic beta cell, [6] an interruption of the function in a thyroid hormone, [7] an obesity acceleration effect, [8] and the induction of an oxidative stress and an inflammation [9] are included.
According to recent studies, the relationship with endocrine related diseases, including diabetes, cardiovascular diseases, liver diseases, and semen abnormalities have brought up constantly. [10, 11] Osteoporosis is a skeletal disease occurred in postmenopausal women and elderly and increases the risk of a bone fracture due to a bone mass reduction and microstructure deterioration. [12] Of the known mechanisms up to date, an estrogen deficiency is the most important factor in the osteoporosis occurrence. [13] Considering the relationship of an estrogen deficiency and an osteoporosis occurrence, a xenoestrogen is also thought to be related to the occurrence of osteoporosis; but until today some studies investigating the relationship of BPA, a xenoestrogen, and bone metabolism have only performed in in vitro or utilizing animals. Suzuki et al. [14] reported that tartrate-resistant acid phosphatase (TRAP) and alkaline phosphatase (ALP), the biochemical bone marker, decreased significantly when injecting BPA in in vitro experiment using goldfish scales. Also Seidlová-Wuttke et al. [15] examined that bone-forming factors increased and boneresorbing factors decreased in the rat group that a higher volume of BPA was injected but a bone mineral density (BMD) decreased. However there was no study investigating the relationship of a blood BPA concentration and osteoporosis in human until today. The objectives of the study were to examine how many patients were exposed to BPA by measuring serum BPA in the patients with osteoporosis and to analyze the relationships with a BMD and a biochemical bone marker.
SUBJECTS AND METHODS

Subjects
In order to examine the relationship between serum BPA concentration and a BMD and a bone marker, the study 
RESULTS
The average age of 51 subjects participated in the study (Table 3) . interests in the study, shows various exposure routes. It is mainly detected from plastic products and widely used for baby bottles, bowls, food containers, and cans as well as the production of epoxyresin which is in the amalgam for the dental clinic. [16] Lately, the exposure of BPA via medical devices has been an issue; it is known that there are highly frequent exposures for the patients with hemodialysis as circulating blood contact the polycarbonate devices of hemodialysis and extract BPA when performing the dialysis.
[17] Furthermore, according to Le et al. [18] , if boiling water was added, there was a 55 fold increase in the BPA concentrations compared to that of room temperature. It is also known that repetitive usages of containers are correlated with increase of BPA concentrations. [19] These absorbed BPA in the body are biological active unconjugated form but quickly conjugated in the liver so that excreted via bile or urine; the half life of this compound is 5.3 hr which is relatively short. [20] [21] [22] The fast excretion of BPA due to its short half life has been adopted for the scientific evidences of BPA safety, but β-glucuronidases in multiples organs, especially lung, liver, and kidneys of rats and placenta of human deconjugate BPA thereby excreting active BPA. The concentrations of BPA in blood of postmenopausal women with osteoporosis were 1.44 ng/mL, which are significant. Compared to the values (0.437 ± 0.036 ng/mL, 83.9% detection rate) of population from the domestic study with uterine myoma patients, [27] these were relatively high levels. Such differences might because of higher exposure and accumulation of BPA in the body owing to relatively high ages and BMI of subjects as well as differences in residential areas. In addition, methods for BPA measurements, subjects, and results from domestic and foreign studies, are listed in Table 4 . Depending upon the research subjects and various conditions, concentrations of BPA in the blood were different; yet it represented the significant association with female hormones related diseases including endometrial hyperplasia, habitual abortion, endometriosis, and polycystic ovary syndrome except for the domestic study with uterine myoma patients Likewise, the osteoporosis is one of the representative 
